(Kepong, Sunday): Malaysia needs more concerted efforts to develop the biotechnology sector such as at least RM300 million for meaningful research in the sector this year, not just RM100 million to set up a Malaysian Life Sciences Capital Fund.

We need billions of ringgit and productive research culture. We must attract funds and experts from within and outside the country. Can the Malaysian Biotechnology Development Corporation attract more investments and joint ventures? It will manage Malaysian Life Sciences Capital Fund that will be launched with a RM100 million contribution from the Government.

The 2006 Budget mentions the Fund, the National Biotechnology Policy and the RM30 million Bioproducts Validation Centre. This is encouraging. But, the shortage of fund, scientists and technologists and the retirement age of 56 are stumbling blocks.

It allocates RM868 million under the Ministry of Science, Technology and Innovation. The Research and Development Grant Scheme will focus on biotechnology, advanced manufacturing, advanced materials, ICT, nanotechnology and alternative sources of energy, including solar, to encourage innovation among local companies and developing new products. How much will biotechnology get? What criteria does the ministry use to decide on R & D projects?

The National Biotechnology Policy launched in April 2005 outlines strategies and initiatives to develop biotechnology. The Malaysian Biotechnology Corporation spearheads the development.
We would like to see the corporation succeed.

We should make the best use of our scientists and other experts. The retirement age should gradually be increased from 56 to at least 65. At 56, a scientists are at the acme of their career. Then, there must be conducive milieu for them. They cannot tolerate mediocrity, feudal mentality and bloodymindedness.